Livzon Pharmaceutical Group ( (HK:1513) ) has shared an announcement.
Livzon Pharmaceutical Group Inc. has announced a final ordinary cash dividend of RMB 11 per 10 shares for the financial year ending December 31, 2024. This announcement reflects the company’s financial health and commitment to delivering shareholder value, although specific details regarding the payment date and exchange rates are yet to be disclosed.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is known for its extensive range of healthcare solutions, catering to various medical needs across different markets.
YTD Price Performance: -1.45%
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.99B
See more data about 1513 stock on TipRanks’ Stock Analysis page.